Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme
Richards, Daniel R.
Kumita, Janet R.
Nilsson, Peter R.
MetadataShow full item record
Bergkvist, L., Richards, D. R., Bernardo-Gancedo, A., Kumita, J. R., Nilsson, P. R., & Brorsson, A. (2020). Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme. https://doi.org/10.1371/journal.pone.0227227
Funder: Stiftelsen Apotekare Hedbergs Fond för Medicinsk Forskning; funder-id: http://dx.doi.org/10.13039/501100009791
Funder: Sthones stiftelse
Many conflicting reports about the involvement of serum amyloid P component (SAP) in amyloid diseases have been presented over the years; SAP is known to be a universal component of amyloid aggregates but it has been suggested that it can both induce and suppress amyloid formation. By using our Drosophila model of systemic lysozyme amyloidosis, SAP has previously been shown to reduce the toxicity induced by the expression of the disease-associated lysozyme variant, F57I, in the Drosophila central nervous system. This study further investigates the involvement of SAP in modulating lysozyme toxicity using histochemistry and spectral analyses on the double transgenic WT and F57I lysozyme flies to probe; i) formation of aggregates, ii) morphological differences of the aggregated lysozyme species formed in the presence or absence of SAP, iii) location of lysozyme and iv) co-localisation of lysozyme and SAP in the fly brain. We found that SAP can counteract the toxicity (measured by the reduction in the median survival time) induced by F57I lysozyme by converting toxic F57I species into less toxic amyloid-like structures, as reflected by the spectral changes that p-FTAA undergoes when bound to lysozyme deposits in F57I-F57I-SAP flies as compared to F57I-F57I flies. Indeed, when SAP was introduced to in vitro lysozyme fibril formation, the endpoint fibrils had enhanced ThT fluorescence intensity as compared to lysozyme fibrils alone. This suggests that a general mechanism for SAP's role in amyloid diseases may be to promote the formation of stable, amyloid-like fibrils, thus decreasing the impact of toxic species formed along the aggregation pathway.
Research Article, Biology and life sciences, Research and analysis methods, Medicine and health sciences, Physical sciences
Torsten Söderbergs Stiftelse (MT9/16)
External DOI: https://doi.org/10.1371/journal.pone.0227227
This record's URL: https://www.repository.cam.ac.uk/handle/1810/301240
Attribution 4.0 International (CC BY 4.0)
Licence URL: https://creativecommons.org/licenses/by/4.0/